Inspire Investing’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-630,072
| Closed | -$2.65M | – | 1337 |
|
|
2026
Q2 | $2.65M | Buy |
630,072
+120,131
| +24% | +$463K | 0.11% | 209 |
|
|
2026
Q1 | $1.79M | Buy |
+509,941
| New | +$2.09M | 0.1% | 222 |
|
|
2025
Q3 | – | Sell |
-552,420
| Closed | -$396K | – | 901 |
|
|
2025
Q2 | $396K | Buy |
552,420
+320,595
| +138% | +$252K | 0.04% | 352 |
|
|
2025
Q1 | $341K | Buy |
231,825
+142,574
| +160% | +$340K | 0.04% | 692 |
|
|
2024
Q4 | $395K | Sell |
89,251
-11,778
| -12% | -$47.8K | 0.04% | 746 |
|
|
2024
Q3 | $416K | Buy |
101,029
+46,352
| +85% | +$249K | 0.04% | 378 |
|
|
2024
Q2 | $356K | Buy |
54,677
+13,908
| +34% | +$98.4K | 0.04% | 384 |
|
|
2024
Q1 | $355K | Buy |
40,769
+6,992
| +21% | +$84.8K | 0.04% | 757 |
|
|
2023
Q4 | $386K | Buy |
33,777
+2,108
| +7% | +$20.9K | 0.04% | 448 |
|
|
2023
Q3 | $305K | Buy |
31,669
+2,294
| +8% | +$22.5K | 0.04% | 745 |
|
|
2023
Q2 | $313K | Sell |
29,375
-45,444
| -61% | -$488K | 0.04% | 724 |
|
|
2023
Q1 | $787K | Buy |
74,819
+55,958
| +297% | +$627K | 0.1% | 177 |
|
|
2022
Q4 | $234K | Sell |
18,861
-2,120
| -10% | -$24K | 0.03% | 729 |
|
|
2022
Q3 | $217K | Buy |
20,981
+2,690
| +15% | +$30.5K | 0.03% | 337 |
|
|
2022
Q2 | $211K | Sell |
18,291
-509
| -3% | -$6K | 0.03% | 667 |
|
|
2022
Q1 | $237K | Sell |
18,800
-2,216
| -11% | -$25.4K | 0.03% | 423 |
|
|
2021
Q4 | $245K | Buy |
21,016
+3,592
| +21% | +$44.1K | 0.03% | 728 |
|
|
2021
Q3 | $228K | Sell |
17,424
-11,814
| -40% | -$153K | 0.03% | 633 |
|
|
2021
Q2 | $376K | Buy |
29,238
+886
| +3% | +$10.1K | 0.05% | 473 |
|
|
2021
Q1 | $317K | Buy |
28,352
+8,636
| +44% | +$91.2K | 0.05% | 507 |
|
|
2020
Q4 | $225K | Buy |
+19,716
| New | +$216K | 0.05% | 579 |
|
|
2020
Q3 | – | Sell |
-22,134
| Closed | -$228K | – | 500 |
|
|
2020
Q2 | $228K | Buy |
22,134
+751
| +4% | +$7.69K | 0.08% | 354 |
|
|
2020
Q1 | $216K | Buy |
21,383
+8,468
| +66% | +$100K | 0.09% | 372 |
|
|
2019
Q4 | $172K | Sell |
12,915
-6,823
| -35% | -$75.2K | 0.06% | 333 |
|
|
2019
Q3 | $169K | Buy |
19,738
+4,333
| +28% | +$42.1K | 0.06% | 362 |
|
|
2019
Q2 | $169K | Buy |
15,405
+1,818
| +13% | +$20.4K | 0.07% | 309 |
|
|
2019
Q1 | $154K | Buy |
+13,587
| New | +$152K | 0.07% | 281 |
|
|
2018
Q1 | – | Sell |
-4,131
| Closed | -$52K | – | 444 |
|
|
2017
Q4 | $52K | Buy |
+4,131
| New | +$54K | 0.04% | 724 |
|
Other funds holding IRWD
Inspire Investing's IRWD Position: Q3 2026 in Review
Inspire Investing sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2026, closing a stake of 630,072 shares — an estimated $2.65M sold.
Inspire Investing first reported a position in IRWD in Q4 2017 and held it in 28 quarters. The position peaked at $2.65M in Q2 2026. 30 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.
- Inspire Investing reported no remaining Ironwood Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Inspire Investing sold 630,072 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $2.65M.
- Inspire Investing first reported a position in Ironwood Pharmaceuticals in Q4 2017 and held it in 28 quarters.
- Inspire Investing's Ironwood Pharmaceuticals position peaked at $2.65M in Q2 2026.
- 30 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.
Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.